🇺🇸 FDA
Patent

US 8999982

Pharmaceutically active compounds as Axl inhibitors

granted A61KA61K31/47A61K31/495

Quick answer

US patent 8999982 (Pharmaceutically active compounds as Axl inhibitors) held by Lead Discovery Center GmbH expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lead Discovery Center GmbH
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/47, A61K31/495, A61P, A61P35/00